• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性腺苷受体 2A 激动剂作为潜在抗炎药物的分子建模方法。

Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs.

机构信息

Graduate Program in Biotechnology and Biodiversity-Network BIONORTE, Federal University of Amapá, Macapá, Brazil.

Laboratory of Modeling and Computational Chemistry, Department of Biological Sciences and Health, Federal University of Amapá, Macapá, Brazil.

出版信息

J Biomol Struct Dyn. 2021 Jun;39(9):3115-3127. doi: 10.1080/07391102.2020.1761878. Epub 2020 May 6.

DOI:10.1080/07391102.2020.1761878
PMID:32338151
Abstract

Adenosine A receptor (AR) is the predominant receptor in immune cells, where its activation triggers cAMP-mediated immunosuppressive signaling and the underlying inhibition of T cells activation and T cells-induced effects mediated by cAMP-dependent kinase proteins mechanisms. In this study, were used ADME/Tox, molecular docking and molecular dynamics simulations to investigate selective adenosine AR agonists as potential anti-inflammatory drugs. As a result, we obtained two promising compounds (A and B) that have satisfactory pharmacokinetic and toxicological properties and were able to interact with important residues of the AR binding cavity and during the molecular dynamics simulations were able to keep the enzyme complexed.Communicated by Ramaswamy H. Sarma.

摘要

腺苷 A 受体 (AR) 是免疫细胞中的主要受体,其激活触发 cAMP 介导的免疫抑制信号转导,以及 cAMP 依赖性激酶蛋白机制介导的 T 细胞激活和 T 细胞诱导效应的潜在抑制。在这项研究中,我们使用 ADME/Tox、分子对接和分子动力学模拟来研究选择性腺苷 AR 激动剂作为潜在的抗炎药物。结果,我们获得了两种有前途的化合物 (A 和 B),它们具有令人满意的药代动力学和毒理学特性,能够与 AR 结合腔的重要残基相互作用,并且在分子动力学模拟过程中能够保持酶复合物的状态。由 Ramaswamy H. Sarma 传达。

相似文献

1
Molecular modeling approaches of selective adenosine receptor type 2A agonists as potential anti-inflammatory drugs.选择性腺苷受体 2A 激动剂作为潜在抗炎药物的分子建模方法。
J Biomol Struct Dyn. 2021 Jun;39(9):3115-3127. doi: 10.1080/07391102.2020.1761878. Epub 2020 May 6.
2
A2a adenosine receptor agonist improves endoplasmic reticulum stress in MIN6 cell line through protein kinase A/ protein kinase B/ Cyclic adenosine monophosphate response element-binding protein/ and Growth Arrest And DNA-Damage-Inducible 34/ eukaryotic Initiation Factor 2α pathways.A2a 腺苷受体激动剂通过蛋白激酶 A/蛋白激酶 B/环腺苷酸反应元件结合蛋白/生长停滞和 DNA 损伤诱导蛋白 34/真核起始因子 2α通路改善 MIN6 细胞系内质网应激。
J Cell Physiol. 2019 Jul;234(7):10500-10511. doi: 10.1002/jcp.27719. Epub 2018 Nov 11.
3
In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulations.基于分子对接策略和动力学模拟的疼痛相关 A1 激动剂和 A2a 抑制剂的计算机筛选。
Purinergic Signal. 2023 Mar;19(1):87-97. doi: 10.1007/s11302-021-09808-4. Epub 2021 Oct 22.
4
Adenosine A2A receptor signaling attenuates LPS-induced pro-inflammatory cytokine formation of mouse macrophages by inducing the expression of DUSP1.腺苷A2A受体信号传导通过诱导双特异性磷酸酶1(DUSP1)的表达来减弱脂多糖(LPS)诱导的小鼠巨噬细胞促炎细胞因子的形成。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt A):1461-71. doi: 10.1016/j.bbamcr.2016.04.003. Epub 2016 Apr 9.
5
Medicinal chemistry of adenosine A2A receptor agonists.腺苷A2A受体激动剂的药物化学
Curr Top Med Chem. 2003;3(4):387-401. doi: 10.2174/1568026033392282.
6
Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects.经鼻给予NECA可在BALB/c小鼠中诱导抗炎和促炎作用:NECA诱导的抗炎作用由A 2A受体亚型介导的证据。
Pulm Pharmacol Ther. 2009 Jun;22(3):243-52. doi: 10.1016/j.pupt.2008.12.012. Epub 2008 Dec 27.
7
Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.腺苷 A2a 受体的配体激活可抑制人单核细胞产生白细胞介素-12。
J Immunol. 2000 Jan 1;164(1):436-42. doi: 10.4049/jimmunol.164.1.436.
8
Novel approaches for targeting the adenosine A2A receptor.靶向腺苷 A2A 受体的新方法。
Expert Opin Drug Discov. 2015 Jan;10(1):63-80. doi: 10.1517/17460441.2015.971006. Epub 2014 Oct 14.
9
Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells.靶向 A2a 受体的遗传和药理学方法可改善抗间皮素 CAR T 细胞的功能。
J Exp Clin Cancer Res. 2020 Mar 10;39(1):49. doi: 10.1186/s13046-020-01546-6.
10
Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.作为抗炎药物的腺苷受体配体开发的最新进展。
Curr Top Med Chem. 2006;6(13):1375-99. doi: 10.2174/15680266106061375.

引用本文的文献

1
Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions.5-乙酰氨基-2-羟基苯甲酸衍生物的镇痛活性及其靶点相互作用的体内和计算机模拟分析
Pharmaceuticals (Basel). 2023 Nov 9;16(11):1584. doi: 10.3390/ph16111584.
2
Multivariate QSAR, similarity search and ADMET studies based in a set of methylamine derivatives described as dopamine transporter inhibitors.基于一组被描述为多巴胺转运体抑制剂的甲胺衍生物的多变量定量构效关系、相似性搜索和药物代谢及毒性研究。
Mol Divers. 2024 Oct;28(5):2931-2946. doi: 10.1007/s11030-023-10724-5. Epub 2023 Sep 6.
3
Variation in the Chemical Composition of Endemic Specimens of J. Koenig from the Amazon and In Silico Investigation of the ADME/Tox Properties of the Major Compounds.
来自亚马逊地区的爪哇胡椒特有标本的化学成分变化及主要化合物的ADME/Tox性质的计算机模拟研究
Plants (Basel). 2023 Jul 12;12(14):2626. doi: 10.3390/plants12142626.
4
Identification of circRNA-miRNA-mRNA Network Regulated by Hsp90 in Human Melanoma A375 Cells.鉴定热休克蛋白 90 调控的人黑色素瘤 A375 细胞中的 circRNA-miRNA-mRNA 网络。
Comb Chem High Throughput Screen. 2024;27(2):307-316. doi: 10.2174/1386207326666230609145247.
5
Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2.设计和鉴定针对 SARS-CoV-2 的刺突-ACE2 靶点的抑制剂。
Int J Mol Sci. 2023 May 16;24(10):8814. doi: 10.3390/ijms24108814.
6
New paradigms in purinergic receptor ligand discovery.嘌呤能受体配体发现的新范式。
Neuropharmacology. 2023 Jun 1;230:109503. doi: 10.1016/j.neuropharm.2023.109503. Epub 2023 Mar 13.
7
Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach.基于加兰他敏的新型乙酰胆碱酯酶抑制剂:一种基于分子模拟设计的方法。
Molecules. 2023 Jan 19;28(3):1035. doi: 10.3390/molecules28031035.
8
Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies.一种新型乙酰胆碱酯酶和丁酰胆碱酯酶双重抑制剂的鉴定:体外和计算机模拟研究
Pharmaceuticals (Basel). 2023 Jan 9;16(1):95. doi: 10.3390/ph16010095.
9
First Report on the Chemical Composition, Antioxidant Capacity, and Preliminary Toxicity to L. of Secco, A. Rosário & PE Berry (Euphorbiaceae) Essential Oil, and In Silico Study.关于大戟科植物塞科、A. 罗萨里奥和PE·贝里精油的化学成分、抗氧化能力及对罗非鱼的初步毒性的首次报告以及计算机模拟研究
Antioxidants (Basel). 2022 Dec 6;11(12):2410. doi: 10.3390/antiox11122410.
10
Computational biophysics approach towards the discovery of multi-kinase blockers for the management of MAPK pathway dysregulation.计算生物物理方法在发现多激酶抑制剂以治疗 MAPK 通路失调中的应用。
Mol Divers. 2023 Oct;27(5):2093-2110. doi: 10.1007/s11030-022-10545-y. Epub 2022 Oct 19.